According to Ocular Therapeutix's latest financial reports and stock price the company's current number of shares outstanding is 79,373,272. At the end of 2023 the company had 79,373,272 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 79.37 M | 3.07% |
2022 | 77.01 M | 0.51% |
2021 | 76.61 M | 8.5% |
2020 | 70.61 M | 45.63% |
2019 | 48.48 M | 18% |
2018 | 41.09 M | 38.56% |
2017 | 29.65 M | 19.16% |
2016 | 24.88 M | 0.63% |
2015 | 24.73 M | 16.17% |
2014 | 21.28 M | 711.32% |
2013 | 2.62 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
SurModics SRDX | 14,102,000 | -82.23% | ๐บ๐ธ USA |
Anika Therapeutics ANIK | 14,635,000 | -81.56% | ๐บ๐ธ USA |
Intersect ENT XENT | 32,559,200 | -58.98% | ๐บ๐ธ USA |
Haemonetics HAE | 50,768,000 | -36.04% | ๐บ๐ธ USA |